EMEA-002319-PIP01-17-M02
Key facts
| Active substance |
Rezafungin acetate
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0342/2022
|
| PIP number |
EMEA-002319-PIP01-17-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of invasive candidiasis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Mundipharma Corporation (Ireland) Limited
E-mail: regaffairs-enquiries@mundipharma-rd.eu |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|